Chicago Atlantic BDC (LIEN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Mar, 2026Executive summary
Focuses on senior secured lending to privately held companies in niche and underserved markets, especially the cannabis sector and lower middle market, aiming for attractive returns and downside protection.
Closed over $3.3B in loans since inception, with $333.3M in total portfolio investment value as of 12/31/2025, across 39 companies.
Net investment income was $8.3M ($0.36 per share) for Q4 2025 and $33.1M ($1.45 per share) for the year, with a yield to book value of 2.7% for Q4 and 11% for the year.
Maintains zero non-accrual loans, high senior secured loan exposure (99.5%-100%), and leverage below industry averages.
Recent M&A activity and positive federal cannabis policy momentum have expanded the investment pipeline.
Financial highlights
Gross investment income for Q4 2025 was $14.2M, down from $15.1M in Q3; full-year gross investment income was $54.3M.
Net investment income for Q4 was $8.3M ($0.36 per share), down from $9.5M ($0.42 per share) in Q3.
Net asset value per share was $13.30 at year-end, up from $13.27 in Q3; total net assets were $303.4M with 22.8M shares outstanding.
Declared a $0.34 dividend for the sixth consecutive quarter, totaling $1.36 per share for the year.
Portfolio fair value grew steadily throughout 2025, reaching $333.3M at year-end.
Outlook and guidance
Pipeline for potential debt transactions grew to over $732M, up from $600M last quarter.
Regulatory reforms, including federal rescheduling of cannabis, are expected to improve revenue visibility, margin durability, and lending opportunities.
Strategy assumes no regulatory change, focusing on high-yield, niche markets with strong credit metrics.
Anticipates continued growth in the cannabis industry, with U.S. retail sales projected to reach $69B by 2031.
Latest events from Chicago Atlantic BDC
- Loan portfolio acquisition tripled net assets and expanded reach to 28 portfolio companies.LIEN
Q3 202414 Mar 2026 - Q1 2025 saw $7.6M net income, $0.34/share dividend, and a $100M credit facility for growth.LIEN
Q1 202514 Mar 2026 - Major portfolio acquisition, strong income, and a $100M credit facility fuel 2024 growth.LIEN
Q4 202414 Mar 2026 - NAV per share fell to $13.56 as a $130M+ loan portfolio acquisition approaches.LIEN
Q2 20242 Feb 2026 - Cannabis lending offers unique risk-reward and is poised for growth as capital markets evolve.LIEN
Fireside chat13 Jan 2026 - Annual meeting to vote on board re-election and auditor, with focus on cannabis lending.LIEN
Proxy Filing2 Dec 2025 - Vote on board re-election and auditor ratification at the June 2025 virtual annual meeting.LIEN
Proxy Filing2 Dec 2025 - Annual meeting to vote on director re-election and auditor ratification, with Board support.LIEN
Proxy Filing2 Dec 2025 - Q2 2025 saw strong income, high yields, and robust liquidity, fueling continued portfolio growth.LIEN
Q2 202523 Nov 2025